Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results.
Hepatology. 2009 Sep;50(3):717-26. doi: 10.1002/hep.23073.
Hepatology. 2009.
PMID: 19585653
Clinical Trial.
Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C.
Poordad F, Lawitz E, Shiffman ML, Hassanein T, Muir AJ, Bacon BR, Heise J, Halliman D, Chun E, Hammond J.
Poordad F, et al.
Hepatology. 2010 Oct;52(4):1208-15. doi: 10.1002/hep.23827.
Hepatology. 2010.
PMID: 20721883
Clinical Trial.
Item in Clipboard
Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients.
Marcellin P, Gish RG, Gitlin N, Heise J, Halliman DG, Chun E, Rodriguez-Torres M.
Marcellin P, et al. Among authors: halliman dg.
J Hepatol. 2010 Jan;52(1):32-8. doi: 10.1016/j.jhep.2009.10.015. Epub 2009 Oct 23.
J Hepatol. 2010.
PMID: 19913323
Clinical Trial.
Item in Clipboard
Relative susceptibilities to vancomycin and quinupristin-dalfopristin of adhered and planktonic vancomycin-resistant and vancomycin-susceptible coagulase-negative staphylococci.
Halliman DG, Ahearn DG.
Halliman DG, et al.
Curr Microbiol. 2004 Mar;48(3):214-8. doi: 10.1007/s00284-003-4091-8.
Curr Microbiol. 2004.
PMID: 15057468
Item in Clipboard
Cite
Cite